Suzhou UgeneX Therapeutics Co., Ltd.

UGX202

clinicaltrials.gov

Phase I/II Open-Label Trial of UGX202 for Advanced Retinitis Pigmentosa

Phase 1Not yet recruiting202612 people29 Sept 2026clinicaltrials.gov